- Lobbying
- spectrum AND pharmaceuticals
Lobbying Arrangements Results for 'Spectrum Pharmaceuticals'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details policies and legislation supporting DOD and VA coverage of FeNO testing |
Circassia Pharmaceuticals
|
THE SPECTRUM GROUP | |||
Details FDA & NRC regulatory issues |
Spectrum Pharmaceuticals, Inc
|
REDROCK GOVERNMENT RELATIONS | |||
Details Regulation of the medical use of nuclear materials and its effect on cancer patient access. |
Spectrum Pharmaceuticals
|
Kasowitz Benson Torres LLP (formerly aka Kasowitz, Benson, Torres, and Friedman, LLP) | |||
Details Nuclear Regulatory Commission requirements for beta emitters. |
Spectrum Pharmaceuticals
|
FOLEY HOAG LLP | |||
Details Issues related to development of oncology treatments |
Spectrum Pharmaceuticals, Inc.
|
JEFFREY J. KIMBELL & ASSOCIATES, INC. | |||
Details Issues related to the development of broad-spectrum antivirals. H.R. 1960/S. 1034, National Defense Authorization Act for Fiscal Year 2014. |
Bay Bridge Strategies, Inc. (on behalf of BioCryst Pharmaceuticals)
|
Tiber Creek Health Strategies, Inc. | |||
Details Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of ... |
Pulmatrix, Inc.
Develops broad spectrum pharmaceuticals & delivery system targeting respiratory diseases |
DALRYMPLE & ASSOCIATES, LLC | |||
Details Issues related to exon 20 cancer mutation. Issues related to FDA remote foreign site inspections |
Spectrum Pharmaceuticals, Inc
|
Farragut Partners LLP | |||
Details FDA - rare and orphan disease issues; Prescription drug coverage and payment policies; Medical innovation issues. Fiscal year 2022 LHHS appropriations report language on Wilson's Disease, Myasthe... |
Alexion Pharmaceuticals
|
NVG, LLC | |||
Details Funding for higher education programs related to research and evaluation within the FY 2024 AG (H.R. 4368/S. 2131), CJS (H.R. 5893/S. 2321), DOD (H.R. 4365/S. 2587), and LHHS (H.R 5894/S.2624). Pol... |
Baylor University
|
Arnold & Porter Kaye Scholer LLP | |||
Details H Res 25 A resolution expressing the support of the House of Representatives for the goals and ideals of National Internet Safety Month all provisions relating to cable; H Res 30 A resolution expr... |
National Cable and Telecommunications Association
|
Utrecht & Phillips, PLLC |